JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Correction for Anderson and Bonnycastle, J Pharmacol Exp Ther 130 (2) 138-143.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anderson, E. G.
Right arrow Articles by Bonnycastle, D. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Anderson, E. G.
Right arrow Articles by Bonnycastle, D. D.
Journal of Pharmacology And Experimental Therapeutics, Vol. 131, Issue 1, 135-135, 1961
Copyright © 1961 by American Society for Pharmacology and Experimental Therapeutics


A STUDY OF THE CENTRAL DEPRESSANT ACTION OF PENTOBARBITAL, PHENOBARBITAL AND DIETHYL ETHER IN RELATIONSHIP TO INCREASES IN BRAIN 5-HYDROXYTRYPTAMINE

Edmund G. Anderson 1 and Desmond D. Bonnycastle 1

1 Department of Pharmacology, Seton Hall College of Medicine and Dentistry, Jersey City, New Jersey

There is an error in a paper by Edmund G. Anderson and Desmond D. Bonnycastle, entitled "A Study of the Central Depressant Action of Pentobarbital, Phenobarbital and Diethyl Ether in Relationship to Increases in Brain 5-Hydroxytryptamine," which appeared in Vol. 130, No. 2, of the Journal (1960). In lines 12-13 of the second complete paragraph on page 141, 100 mg/kg of pentobarbital should read 100 mg/kg of phenobarbital.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1961 by the American Society for Pharmacology and Experimental Therapeutics.